Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Antiplatelet Therapy for Clopidogrel Resistance After Coronary Stenting
NCT01094457Phase 4Completed
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Mar 2009
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol, clopidogrel in acute coronary syndrome (ACS), clopidogrel resistance (HTPR), sponsored by General Hospital of the Northern Theater Command. Started Mar 2009; status: completed.
02
Drugs
cilostazolclopidogrel
03
Conditions
acute coronary syndrome (ACS)clopidogrel resistance (HTPR)
Beyond the preview
Go deeper on NCT01094457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01094457.